{
    "body": "The secreted frizzled-related protein 3 (sFPR3) is altered in human cancers.\nAre its level found to increase or to decrease?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23408665", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20160027", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21494614", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17420170", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17702698", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11798016", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17079093", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16266997"
    ], 
    "ideal_answer": [
        "SFRPs are down-regulated in several cancers and this is often correlated with poor prognosis, as has been shown for breast, colorectal, and a number of other cancers. (PMID: 21494614) We performed tissue microarray and found that the level of sFRP3 protein was high in normal kidney, low in primary renal cancer tissues, and high in metastatic renal cancer tissues. (PMID: 20160027)", 
        "Secreted frizzled-related protein 3 is potentially acting as a tumor suppressor gene, thus it is down-regulated (decreased) in some cancers."
    ], 
    "type": "summary", 
    "id": "5159502dd24251bc0500009b", 
    "snippets": [
        {
            "offsetInBeginSection": 238, 
            "offsetInEndSection": 419, 
            "text": "We performed tissue microarray and found that the level of sFRP3 protein was high in normal kidney, low in primary renal cancer tissues, and high in metastatic renal cancer tissues.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20160027", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1332, 
            "offsetInEndSection": 1484, 
            "text": "In conclusion, this is the first report to show that sFRP3 expression promotes cell growth, invasion, and inhibition of apoptosis in renal cancer cells.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20160027", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 486, 
            "offsetInEndSection": 562, 
            "text": "secreted frizzled-related protein-3 were produced by multiple myeloma cells.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702698", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1837, 
            "offsetInEndSection": 1908, 
            "text": "these data suggest a tumor-suppressive potential for FRZB/sFRP3 in OGS.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17079093", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 269, 
            "text": "The ability of Frzb/secreted Frizzled-related protein 3 (sFRP3) to inhibit Wnt signaling and the localization of Frzb/sFRP3 on chromosome 2q to a region frequently deleted in cancers have led some investigators to hypothesize that Frzb/sFRP3 is a tumor suppressor gene.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16266997", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1575, 
            "offsetInEndSection": 1784, 
            "text": "Together, these data suggest that Frzb/sFRP3 and DN-LRP5 exhibit antitumor activity through the reversal of epithelial-to-mesenchymal transition and inhibition of MMP activities in a subset of prostate cancer.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16266997", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 443, 
            "offsetInEndSection": 531, 
            "text": "secreted frizzled related protein (hsFRP) was found to be down-regulated in some cancer.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11798016", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 597, 
            "offsetInEndSection": 640, 
            "text": "hsFRP is a potential tumor suppressor gene.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11798016", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1181, 
            "offsetInEndSection": 1274, 
            "text": "All these cases were associated with either up-regulation of FzE3 or down-regulation of hsFRP", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11798016", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1221, 
            "offsetInEndSection": 1406, 
            "text": "Since modified Wnt signaling and down-regulation of frizzled-related proteins have been observed in many human cancers, this variant may also affect the susceptibility to other cancers.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17420170", 
            "endSection": "sections.0"
        }
    ]
}